This is to intimate that the Board of Directors of the Company at its meeting held on 09.09.2020, approved: 1. The Merger of INM Technologies Private Limited, a wholly owned subsidiary of the Company with the Company. The detailed disclosure as required under Regulation 30 of SEBI (LODR) Regulations, 2015 is attached hereto as Annexure - A. We hereby submit the disclosure under Regulation 37(6) of SEBI (LODR) Regulations, 2015, in relation to the proposed amalgamation of M/s INM Technologies Private Limited (a wholly owned subsidiary of Shilpa Medicare Limited) with Shilpa Medicare Limited We request you to kindly consider and take the same on record. (As per BSE Announcement Dated on 19/06/2021) Shilpa Medicare Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 30/05/2022) NCLT order on Merger of INM Technologies Private Limited, a wholly owned subsidiary with Shilpa Medicare Limited (As Per BSE Announcement Dated on 28.06.2025) Intimation of certified true copy of NCLT order approving the scheme of amalgamation (As Per BSE Announcement Dated on :05.07.2025)